| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3287595 | Enfermedad Inflamatoria Intestinal al Día | 2016 | 4 Pages |
Abstract
Up to 30% of patients with Crohn's disease are refractory to corticoesteroids. Currently, these patients are treated with inmunosupressive or biologic therapies or surgery. A proper differential diagnosis must be established knowing that many infections can mimic inflamatory bowel disease, and the diagnosis is not always easy. A case of an ileocolonic Crohn's disease refractory to corticosteroid because an Entamoeba histolytica infection in a patient without epidemiologic risk factors is presented.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
M.D. MartÃn Arranz, L. Guerra Pastrian,